706 related articles for article (PubMed ID: 23180948)
21. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
22. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
Kogita S; Imai Y; Okada M; Kim T; Onishi H; Takamura M; Fukuda K; Igura T; Sawai Y; Morimoto O; Hori M; Nagano H; Wakasa K; Hayashi N; Murakami T
Eur Radiol; 2010 Oct; 20(10):2405-13. PubMed ID: 20490505
[TBL] [Abstract][Full Text] [Related]
23. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
24. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
26. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Okuda S; Ogawa S; Igura T; Imai Y
J Gastroenterol; 2015 Jan; 50(1):85-94. PubMed ID: 24563123
[TBL] [Abstract][Full Text] [Related]
28. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
[TBL] [Abstract][Full Text] [Related]
29. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
[TBL] [Abstract][Full Text] [Related]
30. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
[TBL] [Abstract][Full Text] [Related]
31. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
32. Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.
Haimerl M; Wächtler M; Platzek I; Müller-Wille R; Niessen C; Hoffstetter P; Schreyer AG; Stroszczynski C; Wiggermann P
BMC Med Imaging; 2013 Dec; 13():41. PubMed ID: 24289722
[TBL] [Abstract][Full Text] [Related]
33. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
[TBL] [Abstract][Full Text] [Related]
34. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
[TBL] [Abstract][Full Text] [Related]
35. Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Ye F; Liu J; Ouyang H
Medicine (Baltimore); 2015 Aug; 94(32):e1157. PubMed ID: 26266348
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.
Schmid-Tannwald C; Herrmann K; Oto A; Panteleon A; Reiser M; Zech C
Acta Radiol; 2012 Nov; 53(9):961-5. PubMed ID: 23024179
[TBL] [Abstract][Full Text] [Related]
37. Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
Iyama A; Nakaura T; Iyama Y; Kidoh M; Nagayama Y; Oda S; Utsunomiya D; Namimoto T; Morita K; Yuba K; Yamashita Y
Eur Radiol; 2019 Apr; 29(4):2009-2016. PubMed ID: 30255255
[TBL] [Abstract][Full Text] [Related]
38. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
39. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
[TBL] [Abstract][Full Text] [Related]
40. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
